5/9
10:42 am
vyne
VYNE Therapeutics Inc. (VYNE) Reports Q1 Loss, Misses Revenue Estimates [Yahoo! Finance]
Low
Report
VYNE Therapeutics Inc. (VYNE) Reports Q1 Loss, Misses Revenue Estimates [Yahoo! Finance]
5/9
08:12 am
vyne
VYNE Reports First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Low
Report
VYNE Reports First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
5/9
08:00 am
vyne
VYNE Reports First Quarter 2024 Financial Results and Provides Business Update
Medium
Report
VYNE Reports First Quarter 2024 Financial Results and Provides Business Update
5/7
07:39 am
vyne
VYNE Therapeutics receives FDA approval for trial of VYN202 [Yahoo! Finance]
Medium
Report
VYNE Therapeutics receives FDA approval for trial of VYN202 [Yahoo! Finance]
5/6
11:55 am
vyne
VYNE Therapeutics Inc. (NASDAQ: VYNE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.75 price target on the stock.
Low
Report
VYNE Therapeutics Inc. (NASDAQ: VYNE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.75 price target on the stock.
5/6
08:13 am
vyne
VYNE Therapeutics Announces FDA Clearance of IND Application for VYN202, a Novel BD2-Selective BET Inhibitor [Yahoo! Finance]
Low
Report
VYNE Therapeutics Announces FDA Clearance of IND Application for VYN202, a Novel BD2-Selective BET Inhibitor [Yahoo! Finance]
5/6
08:00 am
vyne
VYNE Therapeutics Announces FDA Clearance of IND Application for VYN202, a Novel BD2-Selective BET Inhibitor
Medium
Report
VYNE Therapeutics Announces FDA Clearance of IND Application for VYN202, a Novel BD2-Selective BET Inhibitor
5/1
08:00 am
vyne
VYNE Therapeutics Announces Oral Presentations for VYN201 at the 2024 Society for Investigative Dermatology (SID) Annual Meeting
Medium
Report
VYNE Therapeutics Announces Oral Presentations for VYN201 at the 2024 Society for Investigative Dermatology (SID) Annual Meeting
5/9
04:02 pm
vyne
Form 10-Q VYNE Therapeutics Inc. For: Mar 31
Low
Report
Form 10-Q VYNE Therapeutics Inc. For: Mar 31
5/9
08:01 am
vyne
Form 8-K VYNE Therapeutics Inc. For: May 09
Medium
Report
Form 8-K VYNE Therapeutics Inc. For: May 09
4/3
05:08 pm
vyne
Form 4 VYNE Therapeutics Inc. For: Apr 01 Filed by: Zeronda Tyler
Medium
Report
Form 4 VYNE Therapeutics Inc. For: Apr 01 Filed by: Zeronda Tyler
4/3
05:06 pm
vyne
Form 4 VYNE Therapeutics Inc. For: Apr 01 Filed by: Stuart Iain
Medium
Report
Form 4 VYNE Therapeutics Inc. For: Apr 01 Filed by: Stuart Iain
4/3
05:04 pm
vyne
Form 4 VYNE Therapeutics Inc. For: Apr 01 Filed by: Harsch Mutya
Medium
Report
Form 4 VYNE Therapeutics Inc. For: Apr 01 Filed by: Harsch Mutya
4/3
05:03 pm
vyne
Form 4 VYNE Therapeutics Inc. For: Apr 01 Filed by: Domzalski David
Medium
Report
Form 4 VYNE Therapeutics Inc. For: Apr 01 Filed by: Domzalski David
3/15
06:29 am
vyne
Form EFFECT VYNE Therapeutics Inc.
Low
Report
Form EFFECT VYNE Therapeutics Inc.
3/1
05:17 pm
vyne
Form S-3 VYNE Therapeutics Inc.
Low
Report
Form S-3 VYNE Therapeutics Inc.
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register